Acide Zoledronique
| PRODUCT | Acide zoledronique injectable 4 mg (Lyophilized powder) |
| COMPOSITION | Each vial contains:-Zoledronique monohydrate eq. to Zoledronique acid anhydrous 4 mg |
| INDICATIONS |
Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. Treatment of adult patients with tumour-induced hypercalcaemia (TIH) |
| PACKING TYPE | Glass Vial |
| MEDICINE TYPE | Allopathic |